Pricing Log in Create free account

Lisata Therapeutics, Inc. (LSTA) vs Passage Bio, Inc. (PASG)

Lisata Therapeutics, Inc. and Passage Bio, Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and Passage Bio, Inc. are of similar size ($11.1M and $10.7M). Across the 9 metrics below, Lisata Therapeutics, Inc. leads on 7 and Passage Bio, Inc. on 2.

Valuation

Metric LSTA PASG Biotechnology median
P/E n/m n/m 10.26
P/S 0.60 n/m 9.18
P/B 1.15 2.48 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.34 0.65
EV/Sales 0.13 n/m 8.98
Earnings yield (162.38%) (329.07%) (34.89%)
Free cash flow yield (134.29%) (330.47%) (24.52%)

Profitability

Metric LSTA PASG Biotechnology median
Gross margin 0.49% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) (169.09%) (50.12%)
Return on assets (80.81%) (69.20%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA PASG Biotechnology median
Revenue growth (TTM) (24.67%) — 6.26%
EPS growth (last fiscal year) 20.42% 32.94% 29.88%
Revenue growth, 5-year CAGR (20.28%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 1.22 4.89
Net debt to EBITDA 0.88 0.96 1.01

Dividend

Metric LSTA PASG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LSTA PASG Biotechnology median
Market cap 10.71m 11.13m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack